| 货号 | AF4489-SP |
| 别名 | BoNTA Light Chain; BoNT-A Light Chain | 全称 | Botulinum Neurotoxin Type A Light Chain |
| 应用 | Western Blot(0.1 µg/mL) Immunoprecipitation(25 µg/mL) |
| 目标/特异性 | DetectsC. botulinum BoNTA Light Chain in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 1% cross‑reactivity with recombinant C. botulinum BoNTA Heavy Chain is observed. |
| 使用方法 | Western Blot: 0.1 µg/mL Immunoprecipitation: 25 µg/mL |
| 来源 | Reconstitute at 0.2 mg/mL in sterile PBS. |
| 产品组分 | |
| 是否允许进口 | 否 |
| 是否危险品 | 是 |
| 供应商 | R&D Systems |
| Entrez Gene IDs | 5185061 (C. botulinum) |
| 纯化方式 | Antigen Affinity-purified |
| 免疫原 | E. coli-derived recombinant Clostridium BoNT-A Light Chain Met1-Phe425 Accession # Q45894 |
| 生物活性 | C. botulinum |
| 标记 | Unconjugated |
| 溶解方法 | Reconstitute at 0.2 mg/mL in sterile PBS. |
| 背景 | Botulinum neurotoxin type A is one of the seven serotypes of Botulinum Neurotoxins (BoNTs) produced by various strains of Clostridium botulinum (1, 2). BoNTs are synthesized as inactive single chain protein precursors and activated by proteolytic cleavage to generate disulfide-linked two-chain proteins. The 50 kDa light chain contains the catalytic domain, whereas the 100 kDa heavy chain contains an internal translocation domain and a receptor binding domain (3). BoNTs are the most potent protein toxins for humans. As zinc proteases, they cleave SNARE proteins to elicit flaccid paralysis in botulism by blocking acetylcholine release at the neuromuscular junction (2-4). E. coli-expressed recombinant light chains are active proteases. However, they are not toxic because they cannot enter into host cells in the absence of the heavy chains. |
| 运输条件 | Blue Ice |
| 存放说明 | 4℃ |
| 参考文献 |
|